Xi'an Yicai has declared its intention to expedite the development and operational rollout of the Wuhan initiative. The company is set to partner with investors in a collaborative effort to infuse Wuhan Yicai with a substantial 6.5 billion yuan in fresh capital. This infusion will subsequently be channeled into the Wuhan silicon wafer project.
In detail, Xi'an Yicai is poised to inject an extra 1 billion yuan, while market-oriented strategic investors will collectively contribute 5.5 billion yuan. Additionally, the core employee co-investment platform will add 80 million yuan to the mix. This strategic move has already received the green light from the board of directors and is now awaiting the shareholders' meeting's endorsement.
Although this transaction involves related parties, it does not fall under the category of a major asset restructuring. Once the financing is finalized, Xi'an Yicai will retain its controlling stake in Wuhan Yicai and the Wuhan silicon wafer project, ensuring continued leadership and oversight.